Apollo Medical Holdings Stock Last Dividend Paid
| 3AM Stock | EUR 27.60 1.00 3.50% |
Apollo Medical Holdings fundamentals help investors to digest information that contributes to Apollo Medical's financial success or failures. It also enables traders to predict the movement of Apollo Stock. The fundamental analysis module provides a way to measure Apollo Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollo Medical stock.
Apollo |
Apollo Medical Holdings Company Last Dividend Paid Analysis
Apollo Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Apollo Medical Holdings has a Last Dividend Paid of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Last Dividend Paid (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Apollo Fundamentals
| Current Valuation | 1.28 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 1.14 B | |||
| EBITDA | 112.08 M | |||
| Net Income | 49.05 M | |||
| Total Debt | 203.39 M | |||
| Cash Flow From Operations | 70.33 M | |||
| Number Of Employees | 15 | |||
| Market Capitalization | 197.6 M | |||
| Total Asset | 963.9 M | |||
| Z Score | 1.0 | |||
| Net Asset | 963.9 M |
About Apollo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Apollo Stock
Apollo Medical financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Medical security.